Per-patient costs for clinical trials in Venezuela depend on indication, study complexity, and monitoring. INHRR's 2025 fee schedule puts Phase I–III clinical-trial registration at approximately VES 52,612.41 per protocol, subject to periodic adjustment. We run trials there — and we budget them in USD equivalents for international sponsors.
Per-patient costs for clinical trials in Venezuela depend on indication, study complexity, and monitoring, and we provide a study-specific quote. Those costs sit inside full-service CRO scope: INHRR submission, ethics coordination, site contracting, monitoring with source data verification, and safety reporting.